---
title: "Q32 Bio Enters Underwriting for $18.25 Offering, Net Proceeds ~$188M; Option Lifts to ~$216M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292819329.md"
description: "Q32 Bio entered an underwriting agreement to sell common shares and pre-funded warrants at $18.25, raising net proceeds of approximately $187.6 million, or $215.8 million with full option exercise. The company will use funds for working capital, R&D, and clinical development of bempikibart."
datetime: "2026-07-15T21:23:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292819329.md)
  - [en](https://longbridge.com/en/news/292819329.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292819329.md)
generator: "portal-rs"
---

# Q32 Bio Enters Underwriting for $18.25 Offering, Net Proceeds ~$188M; Option Lifts to ~$216M

Q32 Bio entered into an underwriting agreement to sell 6,027,399 common shares at $18.25 and pre-funded warrants for 4,931,506 shares at $18.2499. Underwriters have a 30-day option to purchase up to 1,643,835 additional shares. Net proceeds are expected to be approximately $187.6 million, or $215.8 million if the option is fully exercised. The company plans to use proceeds for working capital, R&D, clinical development, and advancing bempikibart.

**Agreement details:**

-   **Agreement type**: Underwriting agreement for public offering of common stock and pre-funded warrants
-   **Counterparty**: Morgan Stanley, Jefferies, Cantor Fitzgerald, Oppenheimer
-   **Signed / Effective**: Jul 14 2026 / same
-   **Duration / Termination**: At will
-   **Reason**: Raise capital for R&D and clinical programs

Original SEC Filing: Q32 Bio Inc. \[ QTTB \] - 8-K - Jul. 15, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [QTTB.US](https://longbridge.com/en/quote/QTTB.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)
- [OPY.US](https://longbridge.com/en/quote/OPY.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [REG - Sareum Holdings PLC - Exercise of Warrants](https://longbridge.com/en/news/296362927.md)
- [AMC Robotics Enters into Warrant Inducement Transaction for up to $2.1 Million in Gross Proceeds | AMCI Stock News](https://longbridge.com/en/news/296620340.md)
- [Cell Impact rights issue includes warrants alongside new share issuance](https://longbridge.com/en/news/296309366.md)
- [ReNew Energy Global warrants set to be delisted after expiration](https://longbridge.com/en/news/296360098.md)
- [AMC Robotics issues new warrants in inducement deal raising USD 1 million](https://longbridge.com/en/news/296618045.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**